{
  "insp_id": "166162225020006",
  "layout": "a",
  "customer_id": "37111",
  "customer_name": "Iso-Tex Diagnostics Inc.",
  "customer_addr": "P. O. Box 909\nFriendswood, TX 77549",
  "certificate": "74-R-0185",
  "site_id": "001",
  "site_name": "Iso-Tex Diagnostics Inc.",
  "insp_type": "ROUTINE INSPECTION",
  "date": "14-JUN-2016",
  "report_date": "17-JUN-2016",
  "citations": [
    {
      "code": "2.31(b)(3)(2)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "The unaffiliated member of the IACUC did not attend the last three IACUC meetings held on 5/18/2015, 11/19/2015\nand 5/25/2016. The irregular attendance of this required member of the committee does not demonstrate\nrepresentation of general community interests in the proper care and treatment of animals as intended under the\nAnimal Welfare Act. The unaffiliated member must participate in IACUC activities to signify complete committee\nmembership and function.\nCorrect by: All future IACUC meetings"
    },
    {
      "code": "2.31(c)(3)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Reports of the IACUC semiannual evaluations of the facility inspections and program review have not been\nsubmitted to the Institutional Official for the last three inspections and reviews. No reports were submitted for the\n5/18/15, 11/19/15 and 5/25/16 inspections and reviews. The reports shall be updated every six months upon\ncompletion of the required semiannual evaluations. Updated reports and submission to the IO is required to ensure\nappropriate communication is maintained between the IACUC and IO on issues of facility adherence and\ncompliance with AWA regulations and standards.\nCorrect by: July 16, 2016 for submission of most recent evaluation"
    },
    {
      "code": "2.31(c)(7)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Approved protocol 15-02 using rabbits describes the use of a Ketamine/Xylazine anesthetic cocktail to be\nadministered IM or IV. Discussion with personnel conducting this procedure indicated the drug combination is\nactually given IP. Deviations from protocols related to minimizing pain and distress can be considered significant\nchanges and shall be reviewed and approved by the IACUC prior to implementation. Consideration of topics for\nreview might include appropriateness of route of drug administration according to established species guidelines.\nCorrect by: Immediate"
    },
    {
      "code": "2.31(e)(5)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Approved protocol 15-01 does not contain a complete description of the euthanasia method to be used. Although\nthe protocol states the dosage of Ketamine/Xylazine combination to be given the route of administration of the drugs\nis not documented. The IACUC must ensure that all protocols contain the information required under the AWA\nincluding an appropriate method of euthanasia. Prior to approval the IACUC must confirm that proposed euthanasia\nactivities are conducted using established AVMA guidelines and humane administration.\nCorrect by: Immediate"
    },
    {
      "code": "2.33(a)",
      "kind": "",
      "repeat": false,
      "desc": "ATTENDING VETERINARIAN AND ADEQUATE VETERINARY CARE.",
      "narrative": "The most current written program of veterinary care dated June 2015 is incomplete. The information provided under\nthe euthanasia section does not indicate which drug(s), dose or route of administration will be used for the animals\nat this facility. Since the PVC states that only the registrant will be performing euthanasias it is imperative that a\ncomplete description of the procedure and methods is clearly delineated. Assurance must be provided that\neuthanasia is conducted in accordance with AVMA guidelines.\nCorrect by: June 30, 2016"
    },
    {
      "code": "2.33(b)(4)",
      "kind": "",
      "repeat": false,
      "desc": "ATTENDING VETERINARIAN AND ADEQUATE VETERINARY CARE.",
      "narrative": "*Guinea pigs used under protocol 15 -01 are euthanized using a Ketamine/Xylazine injectable drug combination and\nis stated to be administered at three times the standard anesthetic dose. According to AVMA 2013 euthanasia\nguidelines the use of a dissociative anesthetic in combination with an alpha 2 adrenergic agonist should be\nadministered at five times the anesthetic dose standard when used in laboratory animals for euthanasia.\n*During discussion with personnel responsible for the above described euthanasia procedure the criteria used to\nconfirm death in the guinea pigs after euthanasia and prior to body disposal could not be provided to this inspector.\nThe individual was asked twice how confirmation of death was determined and no answer was given. AVMA\nguidelines and industry standard for humane euthanasia mandate that death must always be confirmed using\nestablished criteria.\nGuidance to principal investigators and personnel involved in the care and use of animals regarding euthanasia\nmust be provided to establish the provision for adequate veterinary care required to be maintained by research\nfacilities. The combination of inadequate euthanasia dosages and lack of confirmation of death prior to body\ndisposal can have painful and distressful consequences for the animals involved. The facility should review\neuthanasia training, methods and techniques to ensure humane handling of animals and adequate veterinary care\nregarding euthanasia that at least parallels accepted veterinary standards.\nCorrect by: June 30, 2016"
    },
    {
      "code": "2.36(a)",
      "kind": "",
      "repeat": false,
      "desc": "ANNUAL REPORT.",
      "narrative": "The current (2015) annual report was signed by the facility on December 2, 2015 and received in the western\nregional office on March 26, 2016. A facility that uses or intends to use live animals in research shall submit an\nannual report to the appropriate regional office on or before December 1 of each calendar year. To comply with the\nregulations and requirements under the Animal Welfare Act all future annual reports shall be filed by December 1.\nCorrect by: All future annual report filings\nThe inspection was conducted with the Quality Assurance Manager and the Inventory Manager.\nThe exit interview was conducted in person on June 16, 2016 with the Laboratory Manager , Health Physics\nSpecialist and Quality Assurance Manager."
    }
  ],
  "narrative": "2.31(b)(3)(2)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nThe unaffiliated member of the IACUC did not attend the last three IACUC meetings held on 5/18/2015, 11/19/2015\nand 5/25/2016. The irregular attendance of this required member of the committee does not demonstrate\nrepresentation of general community interests in the proper care and treatment of animals as intended under the\nAnimal Welfare Act. The unaffiliated member must participate in IACUC activities to signify complete committee\nmembership and function.\nCorrect by: All future IACUC meetings\n2.31(c)(3)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nReports of the IACUC semiannual evaluations of the facility inspections and program review have not been\nsubmitted to the Institutional Official for the last three inspections and reviews. No reports were submitted for the\n5/18/15, 11/19/15 and 5/25/16 inspections and reviews. The reports shall be updated every six months upon\ncompletion of the required semiannual evaluations. Updated reports and submission to the IO is required to ensure\nappropriate communication is maintained between the IACUC and IO on issues of facility adherence and\ncompliance with AWA regulations and standards.\nCorrect by: July 16, 2016 for submission of most recent evaluation\n2.31(c)(7)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nApproved protocol 15-02 using rabbits describes the use of a Ketamine/Xylazine anesthetic cocktail to be\nadministered IM or IV. Discussion with personnel conducting this procedure indicated the drug combination is\nactually given IP. Deviations from protocols related to minimizing pain and distress can be considered significant\nchanges and shall be reviewed and approved by the IACUC prior to implementation. Consideration of topics for\nreview might include appropriateness of route of drug administration according to established species guidelines.\n\nCorrect by: Immediate\n2.31(e)(5)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nApproved protocol 15-01 does not contain a complete description of the euthanasia method to be used. Although\nthe protocol states the dosage of Ketamine/Xylazine combination to be given the route of administration of the drugs\nis not documented. The IACUC must ensure that all protocols contain the information required under the AWA\nincluding an appropriate method of euthanasia. Prior to approval the IACUC must confirm that proposed euthanasia\nactivities are conducted using established AVMA guidelines and humane administration.\nCorrect by: Immediate\n2.33(a)\nATTENDING VETERINARIAN AND ADEQUATE VETERINARY CARE.\nThe most current written program of veterinary care dated June 2015 is incomplete. The information provided under\nthe euthanasia section does not indicate which drug(s), dose or route of administration will be used for the animals\nat this facility. Since the PVC states that only the registrant will be performing euthanasias it is imperative that a\ncomplete description of the procedure and methods is clearly delineated. Assurance must be provided that\neuthanasia is conducted in accordance with AVMA guidelines.\nCorrect by: June 30, 2016\n2.33(b)(4)\nATTENDING VETERINARIAN AND ADEQUATE VETERINARY CARE.\n*Guinea pigs used under protocol 15 -01 are euthanized using a Ketamine/Xylazine injectable drug combination and\nis stated to be administered at three times the standard anesthetic dose. According to AVMA 2013 euthanasia\nguidelines the use of a dissociative anesthetic in combination with an alpha 2 adrenergic agonist should be\nadministered at five times the anesthetic dose standard when used in laboratory animals for euthanasia.\n*During discussion with personnel responsible for the above described euthanasia procedure the criteria used to\nconfirm death in the guinea pigs after euthanasia and prior to body disposal could not be provided to this inspector.\nThe individual was asked twice how confirmation of death was determined  and no answer was given. AVMA\nguidelines and industry standard for humane euthanasia mandate that death must always be confirmed using\nestablished criteria.\nGuidance to principal investigators and personnel involved in the care and use of animals regarding euthanasia\n\nmust be provided to establish the provision for adequate veterinary care required to be maintained by research\nfacilities. The combination of inadequate euthanasia dosages and lack of confirmation of death prior to body\ndisposal can have painful and distressful consequences for the animals involved. The facility should review\neuthanasia training, methods and techniques to ensure humane handling of animals and adequate veterinary care\nregarding euthanasia that at least parallels accepted veterinary standards.\nCorrect by: June 30, 2016\n2.36(a)\nANNUAL REPORT.\nThe current (2015) annual report was signed by the facility on December 2, 2015 and received in the western\nregional office on March 26, 2016. A facility that uses or intends to use live animals in research shall submit an\nannual report to the appropriate regional office on or before December 1 of each calendar year. To comply with the\nregulations and requirements under the Animal Welfare Act all future annual reports shall be filed by December 1.\nCorrect by: All future annual report filings\nThe inspection was conducted with the Quality Assurance Manager and the Inventory Manager.\nThe exit interview was conducted in person on June 16, 2016 with the Laboratory Manager , Health Physics\nSpecialist and Quality Assurance Manager.",
  "animals_total": 4,
  "species": [
    {
      "count": 2,
      "scientific": "Cavia porcellus",
      "common": "DOMESTIC GUINEA PIG"
    },
    {
      "count": 2,
      "scientific": "Oryctolagus cuniculus",
      "common": "EUROPEAN RABBIT"
    }
  ]
}